Phase 2 Clinical Trial to Investigate Novel Hosted Directed Therapeutics Candidates to Acute Respiratory Distress Syndrome (ARDS)
Awarded on December 15, 2023. Full description on SAM.gov.
Overview
- Posted
- December 29, 2023
- Notice type
- Award Notice
- NAICS
- 541715: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Agency
- Department of Health and Human Services
Notice details
- Place of performance
- To be determined based on proposals submitted., New York, NY, 10014
- Last updated
- Dec 6, 2025
- Award date
- Dec 15, 2023
- Award amount (SAM.gov award notice)
- $117.4M
Identifiers
- Solicitation number
- BAA-18-100-SOL-00003
- Notice ID
- 692340ff312e4aeea48301fae6c7b35b
- Award number (PIID)
- 75A50124C00001
Description
Award Overview
Award Number
75A50124C00001
Award Amount (SAM.gov award notice)
$117.4M
Award Date
Dec 15, 2023
Awardee
Awardee UEI
ZANENSW6C665
Original Solicitation
Notice ID: 692340ff312e4aeea48301fae6c7b35b
Posted Date: Dec 29, 2023
Original Response Deadline: Not specified
More From This Vendor
Top 5 most recent
- $20.4MSigned Oct 26, 2026
- $73.2MSigned Oct 14, 2026
- $10.0KSigned Sep 29, 2026
- —Signed Sep 3, 2026
- $26.1MSigned Aug 13, 2026
Contacts
Documents
No documents available.
Lifecycle
BAA-18-100-SOL-00003- Pre-Solicitation
- Solicitation
- Awarded
This opportunity has been awarded.
- 3×Pre-SolicitationOct 16, 2017
Office of Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
- AwardedMar 24, 2018
Office of Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
- 9×Pre-SolicitationJun 12, 2018
Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
- 4×AwardedJul 9, 2019
Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
- SolicitationOct 15, 2019
Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
- 3×AwardedCurrentSep 29, 2022
Phase 2 Clinical Trial to Investigate Novel Hosted Directed Therapeutics Candidates to Acute Respiratory Distress Syndrome (ARDS)
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
BAA-18-100-SOL-00003
Archive Date
Jan 8, 2024
Office Address
Washington, DC, 20201